Eli Lilly Says FDA OKs Jardiance for Kidney Disease

Last Updated: Friday, September 22, 2023 9:38 AM | Bobby Raines

Morning News Leader

Eli Lilly (LLY) and Boehringer Ingelheim said teh FDA approved Jardiance for adults with kidney disease.

InvestorsKeyhole Trade Alert

Share this article:

Related Companies

You May Also Like

Related Articles

Is Abbott Laboratories (ABT) Stock Trading Below Fair Value?

Zimmer Biomet Holdings Inc (ZBH) Stock Is Higher By 0.44% This Week: Buy, Hold, or Sell?

Will Align Technology, Inc. (ALGN) Stay at the Bottom of the Healthcare Sector?

How Will the Market React to Baxter International Inc (BAX) Stock Getting a Bullish Rating

Where Will Henry Schein, Inc. (HSIC) Stock Go Next After It Is Down 1.65% in a Week?

Is Steris PLC (STE) a Leader in the Healthcare Sector?

Related Companies